These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21629805)

  • 1. Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.
    Tausche AK; Wunderlich C; Aringer M
    Case Rep Med; 2011; 2011():397646. PubMed ID: 21629805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenges of gout management in the elderly.
    Stamp LK; Jordan S
    Drugs Aging; 2011 Aug; 28(8):591-603. PubMed ID: 21812496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal failure.
    Maekawa M; Tomida H; Aoki T; Hishida M; Morinaga T; Tamai H
    Intern Med; 2014; 53(6):609-12. PubMed ID: 24633032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Cutaneous Presentation of Chronic Tophaceous Gout: A Case Report.
    Pradhan S; Sinha R; Sharma P; Sinha U
    Indian Dermatol Online J; 2020; 11(2):235-238. PubMed ID: 32477988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated Cutaneous Tophi in a Patient with Chronic Tophaceous Gout and Renal Impairment: A Case Report of a Rare Manifestation of Gout.
    Parlindungan F; Setiyohadi B; Arisanti R
    Am J Case Rep; 2020 Apr; 21():e919349. PubMed ID: 32241962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort.
    Liang N; Sun M; Sun R; Xu T; Cui L; Wang C; Ma L; Cheng X; Xue X; Sun W; Yuan X; Zhang H; Li H; He Y; Ji A; Wu X; Li C
    Arthritis Res Ther; 2019 Sep; 21(1):200. PubMed ID: 31477161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent response to the clinical treatment of tophaceous gout.
    Caldas CA; Fuller R
    Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol.
    Richette P; Bardin T
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):338-42; quiz 343. PubMed ID: 16932713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Febuxostat in the treatment of gout patients with low serum uric acid level: 1-year finding of efficacy and safety study.
    Shen M; Zhang J; Qian K; Li C; Xu W; Gu B; Wang X; Ren Q; Yang L; Yuan H; Su D; Chen X
    Clin Rheumatol; 2018 Nov; 37(11):3107-3113. PubMed ID: 30196323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febuxostat: a new treatment for hyperuricaemia in gout.
    Edwards NL
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii15-ii19. PubMed ID: 19447778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febuxostat for gout.
    Drug Ther Bull; 2010 Jul; 48(7):78-82. PubMed ID: 20631196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of newly available febuxostat in a case of chronic tophaceous gout contraindicated to allopurinol and probenecid.
    Hilmi BA; Asmahan MI; Rosman A
    Med J Malaysia; 2012 Feb; 67(1):125-6. PubMed ID: 22582566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
    Christensen HD; Sheta HM; Morillon MB; Hansen IM
    Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of gout patients with impairment of renal function: a systematic literature review.
    van Echteld IA; van Durme C; Falzon L; Landewé RB; van der Heijde DM; Aletaha D
    J Rheumatol Suppl; 2014 Sep; 92():48-54. PubMed ID: 25180128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout in solid organ transplantation: a challenging clinical problem.
    Stamp L; Searle M; O'Donnell J; Chapman P
    Drugs; 2005; 65(18):2593-611. PubMed ID: 16392875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study.
    Albert JA; Hosey T; LaMoreaux B
    Rheumatol Ther; 2020 Sep; 7(3):639-648. PubMed ID: 32720081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study.
    Perez-Ruiz F; Calabozo M; Fernandez-Lopez MJ; Herrero-Beites A; Ruiz-Lucea E; Garcia-Erauskin G; Duruelo J; Alonso-Ruiz A
    J Clin Rheumatol; 1999 Apr; 5(2):49-55. PubMed ID: 19078356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gout: an overview of available urate lowering therapies].
    Richette P
    Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ERRORS IN THE DIAGNOSTICS AND TREATMENT OF PATIENTS WITH GOUT AND THE ALGORITHM OF THERAPEUTIC TACTICS IN DIFFERENT PERIODS OF THE DISEASE (CLINICAL CASE)].
    Baidurin S; Bekenova F; Nakysh A; Akhmetzhanova S; Abai G
    Georgian Med News; 2020 Jun; (303):103-108. PubMed ID: 32841190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.